VnExpress International on MSN
Boehringer Ingelheim supports animal health development in Vietnam
After one year in Vietnam, Niklas Birkner, Head of Animal Health at Boehringer Ingelheim Vietnam, discusses the company's ...
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
The FDA assigned INO-3107 a Prescription Drug User Fee Act (PDUFA) review goal date of October 30, 2026, which is the date by which it intends to take action on the application. The FDA has indicated ...
Caloocan City/Quezon City. A few days before the much-anticipated countdown to the New Year, the EcoWaste Coalition teamed up ...
Genmab A/S announced today that it will discontinue further clinical development of acasunlimab. This decision was made as part of Genmab's strategic focus on the most value?creating opportunities in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback